Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-07-15
2008-07-15
Yu, Misook (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S387300
Reexamination Certificate
active
10013912
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).
Lewin, B. (Genes VI, Oxford University Press, Inc., NY, Chapter 29, 1997).
Fu et al. (EMBO Journal, 1996, vol. 15, pp. 4392-4401).
Gokman-Polar et al. (Cancer Research (2001) 61:1375-1381).
Konopka et al. (Proc. Natl. Acad. Sci. (1986) 83:4049-4052).
Li et al. (J. Theoretical Biology (2002) 219:513-551).
Ding et al. (Bioinformatics (2003) 19(10):1259-66).
Sawiris et al. (Cancer Research (2002) 62:2923-2928).
Hu et al. (2003, Journal of Proteome Research 2:405-412).
Alberts et al (Molecular Biology of the cell 3rd and 4th Editions).
Lewin (Genes VI, 1997).
Zhigang et al (World Journal of Surgical Oncology 2:13, 2004).
Meric et al (Molecular Cancer Therapeutics, vol. 1, 971-979, 2002).
Wang et al (Urol. Res. 2000), 28(5):308-15).
Munaut et al. (Int. J. Cancer, 2003, 106(6):848-55).
Hui et al. (Leuk. Lymphoma, 2003, 44(8):1385-94).
Khal et al (Int. J. Biochem. Cell Biol., 2005, 37(10):2196-206).
Maruyama et al (Am. J. Patho., 1999, 155(3):815-22).
Caberlotto et al (Neurosci. Lett., 1999, 256(3):191-4).
Misrachi and Shemesh (Biol. Reprod., 1999, 61(3):776-84).
Stein et al (J. Urol., 2000, 164(3 Pt 2): 1026-30).
Gou and xie (Zhonghua Jie He He Hu Xi Za Zhi, 2002, 25(6):337-40).
Futcher et al (Mol. Cell Biol., 1999, 19(11):7357-68).
Godbout et al (J. Biol. Chem., 1998, 273(33):21161-8).
Papotti et al (Virchows-Arch. 2002, 440(5):461-75).
Van der Wilt et al (Euro. J. Cancer, 2003, 39(5):691-7).
Grenback et al (Regul. Pept. 2004, 117(2):127-39).
Shen et al (Blood, 2004, 140(9): 2936-9).
Fu et al (Blood, 2005, 106(13):4315-21).
Bea et al (Cancer Res., 2001, 61(6):2409-12).
Godbnout et al (J. Biol. Chem., 1998, 273(33):21161-8).
Pennica et al (1998, PNAS USA 95:14717-14722).
Greenbaum et al (Genome Biology, 2003, (4):9, 117.1-117.8).
Sen et al (2000, Curr. Opinoin Oncol., 12:82-88).
BLASTN 2.2.1 (Jul. 12, 2001, NCBI; DNA 71282.
BLASTP 2.2.1 (Jul. 12, 2001), NCBI; PRO 1558.
Barkovich et al., J. Biol Chem. 272:9182-9188 (1997).
Dibrov et al., J. Biol. Chem. 272:9175-9181 (1997).
Lee et al., J. Bacteriol. 179:1748-1754 (1997).
Marbois et al., Arch. Biochem. Biophys. 313:83-88 (1994).
Hanna, J.S., et al., “HER-2
eu Breast Cancer Predictive Testing”, Oathology Associates Medical Laboratores, Aug. (1999).
Hyman, Elizabeth, et al., “Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer1,2”,Cancer Research62 6240-6245, Nov. (2002).
Orntoft, Torben F., et al., “Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-Invasive and Invasive Human Transitional Cell Carcinomas”,Molecular&Cellular Proteomics1:37-45, (2002).
Pollack, Jonathan R., et al., “Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors”,PNASvol. 99, 20:12963-12968, Oct. (2002).
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104-9 (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol.,—139(6):860-8 (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713-24 (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787-98 (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409-12 (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dentritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods.—246(1-2):79-90 (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis.—2(6):518-28 (1997) Abstract.
Caberlotto, L. et al., “Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191-4 (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736-46 (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41-6 (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3):279-84 (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC Activity and Expression by TNF-Alpha in Alveolar Epithelial Cells,”Am J. Physio Lung Cell Mol Physiol.—286(2):L301-11 (2004) Abstract.
De Boer, C.J., et al., “Involement of the CCNDI Gene in Hairy Cell Leukemia,”Ann Oncol.—7(3):251-6 (1996) Abstract.
Debieve, F., et al., “Inhibin and Activin Production and Subunit Expression in Human Placental Cells Cultured in Vitro,”Mol Hum Reprod.—6(8):743-9 (2000) Abstract.
Dong, Z., et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected withP. aeruginosa,” Invest Opthalmol Vis Sci.—42(13):3223- (2001) Abstract.
Duchrow, M., et al., “Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR),”Cancer Invest.—19(6):588-96 (2001) Abstract.
Dyer, J., et al., “Molecular Characterisation of Carbohydrate Digestion and Absorption in Equine Small Intestine,”Equine Vet J.—34(4):349-58 (2002) Abstract.
Egwuagu, C.E., et al., “Suppressors of Cytokine Signaling Proteins are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance,”J Immunol.—168(7):3818-7 (2002) Abstract.
El-Ghrably, I.A., et al., “Intravitreal Invading Cells Contribute to Vitreal Cytokine Milieu in Proliferative Vitreoretinopathy,”Br J Opthalmol.—85(4):461-70 (2001) Abstract.
Eleore, L., et al., “Modulation of the Glutamatergic Receptors (AMPA and NMDA) and of Glutamate Vesicular Transporter 2 in the Rat Facial Nucleus after Axotomy,”Neuroscience—136(1):147-60 (2005) Abstract.
Forsberg, H., et al., “Altered Levels of Scavenging Enzymes in Embryos Subjected to a Diabetic Environment,”Free Radic Res.—24(6):451-9 (1996) Abstract.
Freyschuss, B., et al., “Induction of the Estrogen Receptor by Growth Hormone and Glucocorticoid Substitution in Priminary Cultures of Rat Hepatocytes,”Endocrinology—133(4):1548-54 (1993) Abstract.
Fu, K., et al., “Cyclin D1-Negative Mantle Cell Lymphoma: A Clinocopathologic Study Based on Gene Expression Profiling,”Blood—106(13):4315-21 (2005) Abstract.
Fuchs, A.R., et al., “Oxytocin Receptors in Bovine Cervix: Distrubution and Gene Expression During the Estrous Cycle,”Biol
Botstein David
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Roy Margaret Ann
Aeder Sean E
Barnes Elizabeth M.
Dreger Ginger R.
Genentech Inc.
Kresnak Mark T.
LandOfFree
Anti-PRO1558 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-PRO1558 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-PRO1558 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931595